Nonprofit issues challenge to accelerate treatments for every person with CF
Preston W. Campbell, III, President and CEO to retire; Michael P. Boyle, MD, appointed as successor effective January 2020.
|
4 min read
Nonprofit issues challenge to accelerate treatments for every person with CF
Preston W. Campbell, III, President and CEO to retire; Michael P. Boyle, MD, appointed as successor effective January 2020.